| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968497 | Vaccine | 2013 | 8 Pages |
Abstract
⺠Candidate TB vaccine MVA85A is well tolerated intramuscularly or intradermally. ⺠Both routes are highly immunogenic. ⺠MVA85A-induced CD4+ T cell cytokine production was similar between the two routes.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Joel Meyer, Stephanie A. Harris, Iman Satti, Ian D. Poulton, Hazel C. Poyntz, Rachel Tanner, Rosalind Rowland, Kristin L. Griffiths, Helen A. Fletcher, Helen McShane,